Xiqian Zhou

NO.301 Yanchang Middle Road
Shanghai, 200072, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Lactate-Driven Restriction of Mitochondrial Permeability Transition Promotes Resistance to Chemo-Immunotherapy by Suppressing Tumor PANoptosis.

Lactate-Driven Restriction of Mitochondrial Permeability Transition Promotes Resistance to Chemo-Immunotherapy by Suppressing Tumor PANoptosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 18, 2026

Leucine-rich repeat neuronal 1 as a prognostic indicator and functional modulator in breast cancer.

Leucine-rich repeat neuronal 1 as a prognostic indicator and functional modulator in breast cancer.

Journal: Frontiers in oncology
Published: October 14, 2025

Corrigendum to "Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages" [J. Adv. Res. 69 (2025) 125-138].

Corrigendum to "Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages" [J. Adv. Res. 69 (2025) 125-138].

Journal: Journal of advanced research
Published: May 11, 2025

Synergistic inhibition of TNBC by USP33 and TAP63 through autophagy and ferroptosis activation.

Synergistic inhibition of TNBC by USP33 and TAP63 through autophagy and ferroptosis activation.

Journal: Cellular and molecular life sciences : CMLS
Published: December 23, 2024

Leucine-rich repeat-containing 56 promotes breast cancer progression via modulation of the RhoA/ROCKs signaling axis.

Leucine-rich repeat-containing 56 promotes breast cancer progression via modulation of the RhoA/ROCKs signaling axis.

Journal: Molecular biomedicine
Published: August 28, 2024

NASP Promotes Triple-negative Breast Cancer Progression and Metastasis by Stabilizing YAP in a USP15-Dependent Way.

NASP Promotes Triple-negative Breast Cancer Progression and Metastasis by Stabilizing YAP in a USP15-Dependent Way.

Journal: International journal of biological sciences
Published: June 09, 2024

ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.

ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.

Journal: Cell death & disease
Published: January 16, 2024

Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages.

Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages.

Journal: Journal of advanced research
Published: January 11, 2024

K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.

K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.

Journal: Cancer letters
Published: October 15, 2023

LINC01572 promotes triple-negative breast cancer progression through EIF4A3-mediated β-catenin mRNA nuclear exportation.

LINC01572 promotes triple-negative breast cancer progression through EIF4A3-mediated β-catenin mRNA nuclear exportation.

Journal: Environmental toxicology
Published: July 13, 2023

miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer.

miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer.

Journal: Frontiers in oncology
Published: February 15, 2023

DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP.

DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP.

Journal: Cell death & disease
Published: August 14, 2022
Showing 1-12 of 19

Last Updated: 09/26/2026